ZEVRA THERAPEUTICS, INC.
Ticker: 1434647
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 39.66+9.5% | 36.22+39.0% | 26.06+0.7% | 25.88+26.9% | 20.40+451.4% | 3.70-16.9% | 4.45+29.7% | 3.43 |
| Total Income | 39.66+9.5% | 36.22+39.0% | 26.06+0.7% | 25.88+26.9% | 20.40+451.4% | 3.70-16.9% | 4.45+29.7% | 3.43 |
| EXPENSES | ||||||||
| Expenditure | 21.05-16.4% | 25.18+23.6% | 20.37-15.9% | 24.22+6.2% | 22.80-16.0% | 27.15+17.4% | 23.13+4.1% | 22.21 |
| Tax | 4.04-41.5% | 6.91+1707.0% | -0.43-119.5% | 2.20+86.4% | 1.18 | 0.00-100.0% | 0.07+200.0% | -0.07 |
| PROFIT | ||||||||
| PBT | 12.79-71.5% | 44.80+4671.4% | -0.98-101.3% | 76.91+4105.7% | -1.92+94.2% | -33.23-67.3% | -19.86-19.0% | -16.69 |
| Net Profit | 8.75-76.9% | 37.89+7116.7% | -0.54-100.7% | 74.71+2510.0% | -3.10+90.7% | -33.23-66.7% | -19.93-19.9% | -16.62 |
| KEY METRICS | ||||||||
| OPM % | 42.30%-57.70pp | 100.00%+84.10pp | 15.90%+115.89pp | -100.00%-73.72pp | -26.28%+73.72pp | -100.00% | -100.00% | -100.00% |
| NPM % | 22.07%-77.93pp | 100.00%+102.09pp | -2.09%-102.09pp | 100.00%+115.19pp | -15.19%+84.81pp | -100.00% | -100.00% | -100.00% |
| EPS | 0.14-77.4% | 0.62+6300.0% | -0.01-100.8% | 1.24+2166.7% | -0.06+91.3% | -0.69-43.7% | -0.48-20.0% | -0.40 |
Corporate Events
Board MeetingZVRA
20265Aug
Board Meeting
Zevra Therapeutics, Inc. to report corporate and financial r…
SEC Filing ↗ Board MeetingZVRA
20264Jun
Board Meeting
Annual Meeting of Stockholders to elect directors, ratify th…
SEC Filing ↗